Houston, Texas
Alzheimer's disease clinical trials in Houston, TX
14 Alzheimer's disease studies are recruiting participants at sites in Houston as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Houston at a glance
- 14 studies are recruiting at a site in Houston.
- By phase: Phase 1/2 (2), Phase 2 (2), Phase 2/3 (1), Phase 3 (4), No phase (2), Observational (3). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (8), university, hospital or other (6).
- Most recent update to one of these records: November 12, 2026.
Studies recruiting in Houston
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Clinical Trial Network - 7080 Southwest Fwy
- Registry record
- NCT05980949 · updated
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
- Phase 1/2
- Ages 50 to 86
- All sexes
- Sponsor
- The Methodist Hospital Research Institute
- Study site
- Houston Methodist Research Institute
- Registry record
- NCT07651319 · updated
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Phase 2/3
- Ages 55 to 95
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Study sites
- Clinical Trial Network LLC · Kaleidoscope Clinical Research · Prolato Clinical Research Center-Patton
- Registry record
- NCT06159673 · updated
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Study sites
- Houston Methodist Hospital · The University of Texas Health Science Center at Houston
- Registry record
- NCT07589595 · updated
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Phase 3
- Ages 55 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- The University of Texas Health Science Center at Houston
- Registry record
- NCT07602582 · updated
NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
- No phase
- Ages 55 to 90
- All sexes
- Sponsor
- Chi-Ying (Roy) Lin
- Study site
- Baylor College of Medicine
- Registry record
- NCT07667478 · updated
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Clinical Trial Network - 7080 Southwest Fwy
- Registry record
- NCT05511363 · updated
Epidemiology and Biomarker Study in Alzheimer's Disease
- Phase 3
- Ages 55 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Care Access - Houston
- Registry record
- NCT07142954 · updated
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Bryan Denny
- Study site
- Rice University
- Registry record
- NCT05949047 · updated
Stem Cell Therapy for Early Alzheimer's Disease
- Phase 1/2
- Ages 60 to 80
- All sexes
- Sponsor
- Paul E Schulz
- Study site
- The University of Texas Health Science Center at Houston (UTHealth)
- Registry record
- NCT06775964 · updated
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Observational
- Ages 60 to 90
- All sexes
- Sponsor
- GAP Innovations, PBC
- Study site
- Re:Cognition Health
- Registry record
- NCT06584357 · updated
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
- Observational
- Ages 18 to 90
- All sexes
- Sponsor
- The Methodist Hospital Research Institute
- Study site
- Houston Methodist Research Institute
- Registry record
- NCT05582200 · updated
Phosphorylated Tau Levels in Donated Blood
- Observational
- All ages
- All sexes
- Sponsor
- The University of Texas Health Science Center, Houston
- Study site
- University of Texas Health Science Center at Houston
- Registry record
- NCT07157839 · updated
Open-label Extension Study in Participants With Early Alzheimer's Disease
- Phase 2
- Ages 50 to 85
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07105709 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Houston, TX on ClinicalTrials.gov.
Ask about studies near Houston
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
47 studies recruiting across 23 cities.
Austin
11 studies recruiting.
Dallas
11 studies recruiting.
Cypress
8 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections